Eli N. Glezer

All filings by Eli N. Glezer on record concern Singular Genomics Systems, Inc. In total, 15 filings cover trades dated from 12 December 2022 to 21 February 2025.

Purchases make up the whole of the open-market record (3 purchases, €302k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 11 option exercises.

A typical purchase (the median) is worth €95k. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 25 February 2025, the filings show a transaction in Singular Genomics Systems, Inc. The last purchase on record was published on 20 November 2023, which is 1,063 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.